[HTML][HTML] Artificial intelligence and machine learning in cancer pain: a systematic review

V Salama, B Godinich, Y Geng… - Journal of pain and …, 2024 - Elsevier
Abstract Background/Objectives: Pain is a challenging multifaceted symptom reported by
most cancer patients. This systematic review aims to explore applications of artificial …

Moving towards the use of artificial intelligence in pain management

R Antel, S Whitelaw, G Gore… - European Journal of …, 2025 - Wiley Online Library
Abstract Background and Objective While the development of artificial intelligence (AI)
technologies in medicine has been significant, their application to acute and chronic pain …

Multidimensional statistical technique for interpreting the spontaneous breakthrough cancer pain phenomenon. A Secondary Analysis from the IOPS-MS Study

M Cascella, A Crispo, G Esposito, CA Forte, S Coluccia… - Cancers, 2021 - mdpi.com
Simple Summary Pain is one of the most common and debilitating symptoms in cancer
patients. A clinical peculiarity of cancer pain is the breakthrough cancer pain (BTcP), which …

[HTML][HTML] High-rate breakthrough cancer pain and tumour characteristics–literature review and case series

A Cuomo, A Boutis, F Colonese, D Nocerino - Drugs in Context, 2023 - ncbi.nlm.nih.gov
Cancer pain requires careful comprehensive patient evaluation and an appropriate and
personalized clinical approach by a trained multidisciplinary team. The proper assessment …

Patients' satisfaction with breakthrough cancer pain therapy: A secondary analysis of IOPS-MS study

M Mazzotta, M Filetti, M Piras… - Cancer Management …, 2022 - Taylor & Francis
Background Cancer pain is one of the most important symptoms for patients.
Pharmacological control is central for clinical management and to ensure well-being. In …

[HTML][HTML] Relationship between breakthrough cancer pain, background cancer pain and analgesic treatment–case series and review of the literature

C Batistaki, M Graczyk, M Janecki… - Drugs in …, 2022 - ncbi.nlm.nih.gov
The assessment and treatment of breakthrough cancer pain (BTcP) remain a major
challenge in medicine due to its high impact on several aspects of health-related quality of …

Artificial intelligence and opioid use: a narrative review

S Gadhia, GCRT Marriott, J Rose - 2022 - innovations.bmj.com
1,246,642 Boosted tree Prediction of opioid overdoses among prescription opioid users The
boosted tree classifier outperformed other learning algorithms (c-statistic 0.77). The most …

[HTML][HTML] Fentanyl in cancer pain management: avoiding hasty judgments and discerning its potential benefits

A Cuomo - Drugs in Context, 2023 - ncbi.nlm.nih.gov
Cancer pain is an important challenge in treatment and requires a rapid onset of action for
its control. In particular, breakthrough cancer pain (BTcP) should be adequately controlled …

[HTML][HTML] Multidisciplinary approach, continuous care and opioid management in cancer pain: case series and review of the literature

G Porzio, A Capela, R Giusti, FL Bianco, M Moro… - Drugs in …, 2023 - ncbi.nlm.nih.gov
Underlying cancer pain has heterogenous aetiologies and mechanisms. It requires detailed
and comprehensive pain assessment, combined with personalized treatment. A …

Assessing Gender Differences for Non-Predictable Breakthrough Cancer Pain Phenomenon: A Secondary Analysis from IOPS-MS Study

S Bimonte, P Di Gennaro, A Crispo… - Journal of Pain …, 2024 - Taylor & Francis
Purpose Breakthrough cancer pain (BTcP) is a temporary exacerbation of pain that “breaks
through” a phase of adequate pain control by an opioid-based therapy. The non-predictable …